[1]Monteith GR, Prevarskaya N, RobertsThomson SJ. The calciumcancer signalling nexus[J]. Nat Rev Cancer, 2017, 17(6):367-380.
[2]Bong AHL, Monteith GR. Calcium signaling and the therapeutic targeting of cancer cells[J]. Biochim Biophys Acta Mol Cell Res, 2018, 1865(11 Pt B):1786-1794.
[3]曹天生.钙通道阻滞剂与肿瘤化疗[J]. 腹部外科, 1997,10(3): 140-142.
[4]朱林忠, 朱旭, 杨仁杰, 等.化疗药与维拉帕米、利多卡因和法莫替丁联用对肝癌细胞系的影响[J]. 中国实验诊断学, 2012, 16(1): 90-92.
[5]Zhang Y, Zhang J, Jiang D, et al. Inhibition of Ttype Ca2+ channels by endostatin attenuates human glioblastoma cell proliferation and migration[J]. B J Pharmacol, 2012, 166(4): 1247-1260.
[6]Valerie NC, Dziegielewska B, Hosing As, et al. Inhibition of Ttype calcium channels disrupts Akt signaling and promotes apoptosis in glioblastoma cells[J]. Biochem Pharmacol, 2013, 85(7): 888-897.
[7]Bertolesi GE, Shi C, Elbaum L, et al. The Ca2+ channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms[J]. Mol Pharmacol, 2002, 62(2): 210-219.
[8]Taylor JT, Huang L, Pottle JE, et al. Selective blockade of Ttype Ca2+ channels suppresses human breast cancer cell proliferation[J]. Cancer Letters, 2008, 267(1): 116-124.
[9]Das A, Pushparaj C, Herroes J, et al. Ttype calcium channel blockers inhibit autophagy and promote apoptosis of malignant melanoma cells[J]. Pigment Cell Melanoma Res, 2013, 26(6): 874-885.
[10]Xue L, Firestone GL, Bjeldanes LF, et al. DIM stimulates IFNγ gene expression in human breast cancer cells via the specific activation of JNK and p38 pathways[J]. Oncogene, 2005, 24(14): 2343-2353.
[11] Jiang YY, Fang YF, Ye Y, et al. Anticancer effects of 3, 3′diindolylmethane on human hepatocellular carcinoma cells is enhanced by calcium ionophore: the role of cytosolic Ca2+ and p38 MAPK[J]. Front Pharmacol, 2019, 10:1167.
[12]Savino JA, Evans JF, Rabinowitz D, et al. Multiple, disparate roles for calcium signaling in apoptosis of human prostate and cervical cancer cells exposed to diindolylmethane[J]. Mol Cancer Ther, 2006, 5(3): 556-563.
[13]Taghizadehghalehjoughi A, Sezen S, Hacimuftuoglu A, et al. Vincristine combination with Ca2+ channel blocker increase antitumor effects[J]. Mol Biol Rep, 2019, 46(2):2523-2528.
[14]Barceló C, Sisó P, Maiques O, et al. Ttype calcium channels as potential therapeutic targets in vemurafenibresistant BRAFV600E melanoma[J]. J Invest Dermatol, 2020, 140(6):1253-1265.
[15]He H, Qiao K, Wang C, et al. Hydrazinocurcumin induces apoptosis of hepatocellular carcinoma cells through the p38 MAPK pathway[J]. Clin Transl Sci, 2020. Online ahead of print.
[16]Grossi V, Peserico A, Tezil T, et al.P38α MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance[J]. World J Gastroenterol, 2014, 20(29):9744-9758.
[17]Rizzuto R, Pinton P, Ferrari D, et al. Calcium and apoptosis: facts and hypotheses[J]. Oncogene, 2003, 22(53): 8619-8627.
[18]Sazonova OV, Blishchenko EY, Tolmazova AG, et al. Stimulation of fibroblast proliferation by neokyotorphin requires Ca influx and activation of PKA, CaMK Ⅱ and MAPK/ERK[J]. Febs J, 2007, 274(2): 474-484.
[19]Maga G, Mossi R, Fischer R, et al. Phosphorylation of the PCNA binding domain of the large subunit of replication factor C by Ca2+/calmodulindependent protein kinase Ⅱ inhibits DNA synthesis[J]. Biochemistry, 1997, 36(18):5300-5310.
[20]Mutazina DA, Chung D, Ulloa A, et al. TRPC1, STIM1, and ORAI influence signalregulated intracellular and endoplasmic reticulum calcium dynamics in human myometrial cells[J]. Biol Reprod, 2011, 85(2): 315-326.
[21]Dziegielewska B, Brautigan DL, Larner JM, et al. Ttype Ca2+ channel inhibition induces p53dependent cell growth arrest and apoptosis through activation of p38MAPK in colon cancer cells[J]. Mol Cancer Res, 2014, 12(3):348-358.
|